Mayo Clinic

Mayo Clinic
Department of Laboratory Medicine and Pathology
200 First Street SW
ROSU 1-120-AA
Rochester, MN 55905
ComACC Accredited: 1976

Program DirectorAssociate DirectorProgram Admin
Maria Alice V. Willrich, Ph.D., DABCCJeff W. Meeusen, Ph.D., DABCCAnn M. Mairose
Associate Professor of Laboratory Medicine and PathologyAssistant Professor of Laboratory Medicine and PathologyProgram Coordinator
Willrich.MariaAlice@mayo.eduMeeusen.Jeffrey@mayo.eduMairose.Ann@mayo.edu
(507) 266-4909(507) 284-9939(507) 293-2866

About the Program

Training in the Clinical Chemistry Postdoctoral Fellowship is divided into two phases. The first phase is a highly structured eleven-month introduction to clinical laboratory systems and services. Through one-on-one interaction, lectures, case presentations, and laboratory exercises, trainees learn the basic principles of analysis, the pathophysiology of disease, and the application of clinical chemistry to diagnosis. There are multiple rotations through the different laboratories in the divisions of clinical core laboratory services and clinical biochemistry and immunology. The curriculum is aligned with the ABCC/ComACC core competencies expectations for clinical chemists. Content is shared and taught by specialized faculty experts in clinical chemistry, hematology, immunology, cell kinetics, and laboratory genetics. In the second phase, or the final 12-13 months, trainees select one of the clinical laboratories they rotated through during first year and assume increasing responsibility serving in an “acting laboratory directorship” role. Laboratory and patient problems help prepare for the ultimate role as a clinical laboratory director, assistant director, or developmental scientist or manager in a diagnostic-related company. During the second year of fellowship, senior fellows will serve as mentors to junior fellows. Translation research projects started on the first year of fellowship are expected to be fully completed and published in the second year. Second year projects are generally more complex, longer-term projects. There are opportunities for an elective four-week rotation to the Mayo Clinic campus in Phoenix, Arizona, or Jacksonville, Florida, during training.

Program Requirements

To be considered for the program, prospective fellows must have:

  1. a PhD or MD degree by the program start date, with strong background in chemistry or biochemistry.

Eligibility of candidates to enter the program aligns with the American Board of Clinical Chemistry (ABCC) pre-requisites.

To Apply

The deadline for applications is August 15 of the year prior to the anticipated start date. The Program Director and the Associate Program Director each review application files independently, choose the top candidates respectively and subsequently meet to narrow their choices to 6-8 candidates for a Zoom call. These initial video interviews may be conducted with prime candidates in an effort to narrow the field, so that 3-4 would be invited to be on campus in person. The Program Director contacts each of the top candidates to extend an invitation to interview. Upon acceptance of an offer to interview, the Education Program Coordinator will contact the candidate via email to arrange the interview date. Mayo Clinic provides lodging for the night prior to the interview. Applicants are responsible for travel arrangements and associated costs. On-campus interview days may consist of panel interviews, candidate research presentation, campus tours and meetings with current fellows. Interviews will happen September 1st onwards. Offers will be made October 1st onwards and stand valid for a maximum of 2 weeks.

The application packet must include:

  1. Recruit electronic application
  2. Three letters of recommendation (one must be from current advisor or supervisor)
  3. Copy of diploma from graduate school or medical school
  4. Dean’s letter (if candidate is MD)
  5. Official final transcripts
  6. Official test transcripts for all applicable examinations
  7. Personal statement of professional goals and interest in Clinical Chemistry
  8. Curriculum vitae

Training Level

Postdoctoral Training Level
Number of positions available per year: 2 per year
Duration of program: 2 years
Approximate annual salary or stipend: PGY Scale
Source of funding: Supported by Mayo Foundation and Department of Laboratory Medicine and Pathology
Current number of trainees: 4
Number of past graduates: 91

Faculty

Alicia Algeciras-Schimnich, PhD, DABCCTumor Markers, Endocrinology, Alzheimer’s Disease
Aneel Ashrani, MD, ABIMCoagulation
Irina Bancos, MD, ABIMEndocrinology, Adrenal Tumors
Linnea Baudhuin, PhD, ABMGGCardiovascular Genomics, Pharmacogenomics
Nikola Baumann, PhD, DABCCGeneral Clinical Chemistry, Quality Assurance, Laboratory Automation
Darci Block, PhD, DABCCGeneral Clinical Chemistry, Informatics, Body fluids
Joshua Bornhorst, PhD, DABCCTumor Markers, Endocrinology, Alzheimer’s, Heavy Metals Testing
Leslie Donato, PhD, DABCCGeneral Clinical Chemistry, Point-of-Care Testing, Cardiovascular Laboratory Medicine
Stefan Grebe, MD, PhD, DABCCEndocrinology, Mass Spectrometry
Jennifer Herrick, MD, ABP-AP/CPMetabolic Hematology, Non-neoplastic Red Blood Cell Disorders
Nicole Hoppman, PhD, ABMGGLaboratory Genetics and Genomics
Allan Jaffe, MD, ABIMCardiovascular Laboratory Medicine
Paul Jannetto, PhD, DABCCMass Spectrometry, Toxicology, Therapeutic Drug Monitoring, Heavy Metals Testing
Brad Karon, MD, PhD, ABP-CPGeneral Clinical Chemistry, Electrolytes, Leadership and Education
Brooke Katzman, PhD, NRCCGeneral Clinical Chemistry, Preanalytical Interferences, Laboratory Test Utilization
Attila Kumanovics, MD, ABP-CP, ABMGGCellular and Molecular Immunology, Genetics
Loralie Langman, PhD, DABCC, DABFT, CACBToxicology
Timothy Larson, MD, ABIMRenal Laboratory Medicine
John C. Lieske, MD, ABIMRenal Laboratory Medicine
Dietrich Matern, MD, ABMGGBiochemical Genetics
Andrew McKeon, MBBCh, MD, DABMLIAutoimmune Neurology Laboratory Testing
Jeff Meeusen, PhD, DABCCGeneral Clinical Chemistry, Cardiovascular Laboratory Medicine, Data science
John Mills, PhD, DABCC, ABMGGAutoimmune Neurology Laboratory Testing, Autoantibody Discovery
Ann Moyer, MD, PhD, ABP-AP/CP, MGPGenetics, Pharmacogenomics
David Murray, MD, PhD, ABP-AP/CP, FASCPSpecial Protein Testing, Monoclonal Gammopathies, Mass Spectrometry
Sean Pittock, MD, ABPNAutoimmune Neurology Laboratory Testing
Ross Rowsey, PhD, ABMGGLaboratory Genetics and Genomics
Amir Sadighi Akha, MD, PhDCellular and Molecular Immunology
David Sas, DO, ABP, NBMERenal Laboratory Medicine
Melissa R Snyder, PhD, DABCCAutoimmune Disease Testing, Monoclonal Antibody Therapies
Anne Tebo, PhD, DABMLIAutoimmune Disease Testing
Elitza Theel, PhD, DABMMMicrobiology Serology
Silvia Tortorelli, MD, PhD, ABMGGBiochemical Genetics
Patrick Vanderboom, PhD, DABCCAutoimmune Disease Testing, Artificial Intelligence, Data Science, Mass Spectrometry
Vlad Vasile, MD, PhD, ABIMCardiovascular Laboratory Medicine
Maria Alice Vieira Willrich, PhD, DABCCGeneral Clinical Chemistry, Monoclonal Gammopathies, Monoclonal Antibodies, Complement System
Joseph Yao, MD, ABIM, ABMMMicrobiology Serology, COVID, HIV and Hepatitis Testing
Anastasia Zekeridou, MD, PhD, SGKN, ECFMG, FMHAutoimmune Neurology Laboratory Testing